0001628280-20-004839.txt : 20200409
0001628280-20-004839.hdr.sgml : 20200409
20200409144650
ACCESSION NUMBER: 0001628280-20-004839
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200408
FILED AS OF DATE: 20200409
DATE AS OF CHANGE: 20200409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strauss David Eric
CENTRAL INDEX KEY: 0001799869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 20784071
MAIL ADDRESS:
STREET 1: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_158645799377226.xml
FORM 4
X0306
4
2020-04-08
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001799869
Strauss David Eric
C/O BELLICUM PHARMACEUTICALS, INC.
611 GATEWAY BLVD., SUITE 820
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Director, Corporate Controller
Restricted Stock Units
2020-04-08
4
A
0
6984
0
A
Common Stock
6984.0
6984
D
Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
The RSUs vest in full on April 8, 2021.
/s/ David E. Strauss
2020-04-09